drugset / Trial / NCT00290134

A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism

NCT00290134 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether one or more fispemifene dose regimens are more effective than placebo in the treatment of hypogonadism in older men.

Timeline

Start
2006-02
Primary completion
—
Completion
2007-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fispemifene Small molecule 100 mg Oral
Subject Fispemifene Small molecule 200 mg Oral
Subject Fispemifene Small molecule 300 mg Oral

Indications